These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 28874377)

  • 1. High-Level Resistance to Colistin Mediated by Various Mutations in the
    Jayol A; Nordmann P; Brink A; Villegas MV; Dubois V; Poirel L
    Antimicrob Agents Chemother; 2017 Nov; 61(11):. PubMed ID: 28874377
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Amino Acid Substitutions of CrrB Responsible for Resistance to Colistin through CrrC in Klebsiella pneumoniae.
    Cheng YH; Lin TL; Lin YT; Wang JT
    Antimicrob Agents Chemother; 2016 Jun; 60(6):3709-16. PubMed ID: 27067316
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A putative RND-type efflux pump, H239_3064, contributes to colistin resistance through CrrB in Klebsiella pneumoniae.
    Cheng YH; Lin TL; Lin YT; Wang JT
    J Antimicrob Chemother; 2018 Jun; 73(6):1509-1516. PubMed ID: 29506266
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resistance to colistin associated with a single amino acid change in protein PmrB among Klebsiella pneumoniae isolates of worldwide origin.
    Jayol A; Poirel L; Brink A; Villegas MV; Yilmaz M; Nordmann P
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4762-6. PubMed ID: 24914122
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clonal emergence of Klebsiella pneumoniae ST14 co-producing OXA-48-type and NDM carbapenemases with high rate of colistin resistance in Dubai, United Arab Emirates.
    Moubareck CA; Mouftah SF; Pál T; Ghazawi A; Halat DH; Nabi A; AlSharhan MA; AlDeesi ZO; Peters CC; Celiloglu H; Sannegowda M; Sarkis DK; Sonnevend Á
    Int J Antimicrob Agents; 2018 Jul; 52(1):90-95. PubMed ID: 29530587
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo emergence of colistin resistance in Klebsiella pneumoniae producing KPC-type carbapenemases mediated by insertional inactivation of the PhoQ/PhoP mgrB regulator.
    Cannatelli A; D'Andrea MM; Giani T; Di Pilato V; Arena F; Ambretti S; Gaibani P; Rossolini GM
    Antimicrob Agents Chemother; 2013 Nov; 57(11):5521-6. PubMed ID: 23979739
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative genome analysis of colistin-resistant OXA-48-producing Klebsiella pneumoniae clinical strains isolated from two Iranian hospitals.
    Bolourchi N; Shahcheraghi F; Giske CG; Nematzadeh S; Noori Goodarzi N; Solgi H; Badmasti F
    Ann Clin Microbiol Antimicrob; 2021 Oct; 20(1):74. PubMed ID: 34688302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vivo evolution to colistin resistance by PmrB sensor kinase mutation in KPC-producing Klebsiella pneumoniae is associated with low-dosage colistin treatment.
    Cannatelli A; Di Pilato V; Giani T; Arena F; Ambretti S; Gaibani P; D'Andrea MM; Rossolini GM
    Antimicrob Agents Chemother; 2014 Aug; 58(8):4399-403. PubMed ID: 24841267
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genomic Characterization of Colistin Heteroresistance in Klebsiella pneumoniae during a Nosocomial Outbreak.
    Halaby T; Kucukkose E; Janssen AB; Rogers MR; Doorduijn DJ; van der Zanden AG; Al Naiemi N; Vandenbroucke-Grauls CM; van Schaik W
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6837-6843. PubMed ID: 27600049
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colistin Resistance in KPC-2- and SHV-5-Producing Klebsiella pneumoniae Clinical Isolates in Bulgaria.
    Savov E; Todorova I; Politi L; Trifonova A; Borisova M; Kioseva E; Tsakris A
    Chemotherapy; 2017; 62(6):339-342. PubMed ID: 28738348
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Spread of Carbapenem and Colistin-Resistant Klebsiella pneumoniae ST512 Clinical Isolates in Israel: A Cause for Vigilance.
    Lalaoui R; Bakour S; Livnat K; Assous MV; Diene SM; Rolain JM
    Microb Drug Resist; 2019; 25(1):63-71. PubMed ID: 30129868
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of porin expression in Klebsiella pneumoniae Carbapenemase (KPC)-producing K. pneumoniae identifies isolates most susceptible to the combination of colistin and carbapenems.
    Hong JH; Clancy CJ; Cheng S; Shields RK; Chen L; Doi Y; Zhao Y; Perlin DS; Kreiswirth BN; Nguyen MH
    Antimicrob Agents Chemother; 2013 May; 57(5):2147-53. PubMed ID: 23459476
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The mgrB gene as a key target for acquired resistance to colistin in Klebsiella pneumoniae.
    Poirel L; Jayol A; Bontron S; Villegas MV; Ozdamar M; Türkoglu S; Nordmann P
    J Antimicrob Chemother; 2015 Jan; 70(1):75-80. PubMed ID: 25190723
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heteroresistance to colistin in Klebsiella pneumoniae associated with alterations in the PhoPQ regulatory system.
    Jayol A; Nordmann P; Brink A; Poirel L
    Antimicrob Agents Chemother; 2015 May; 59(5):2780-4. PubMed ID: 25733503
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evaluation of rapid polymyxin NP test to detect colistin-resistant Klebsiella pneumoniae isolated in a tertiary Greek hospital.
    Malli E; Florou Z; Tsilipounidaki K; Voulgaridi I; Stefos A; Xitsas S; Papagiannitsis CC; Petinaki E
    J Microbiol Methods; 2018 Oct; 153():35-39. PubMed ID: 30144479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proteomic Changes of Klebsiella pneumoniae in Response to Colistin Treatment and
    Sun L; Rasmussen PK; Bai Y; Chen X; Cai T; Wang J; Guo X; Xie Z; Ding X; Niu L; Zhu N; You X; Kirpekar F; Yang F
    Antimicrob Agents Chemother; 2020 May; 64(6):. PubMed ID: 32229491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MgrB inactivation is a common mechanism of colistin resistance in KPC-producing Klebsiella pneumoniae of clinical origin.
    Cannatelli A; Giani T; D'Andrea MM; Di Pilato V; Arena F; Conte V; Tryfinopoulou K; Vatopoulos A; Rossolini GM;
    Antimicrob Agents Chemother; 2014 Oct; 58(10):5696-703. PubMed ID: 25022583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of ISEcp1-associated bla
    Ferreira ML; Gonçalves IR; Araújo BF; Royer S; Campos PA; Batistão DWDF; Cerdeira LT; de Brito CS; Gontijo-Filho PP; Ribas RM
    Int J Antimicrob Agents; 2018 May; 51(5):810-811. PubMed ID: 29432869
    [No Abstract]   [Full Text] [Related]  

  • 19. Genomic and transcriptomic analyses of colistin-resistant clinical isolates of Klebsiella pneumoniae reveal multiple pathways of resistance.
    Wright MS; Suzuki Y; Jones MB; Marshall SH; Rudin SD; van Duin D; Kaye K; Jacobs MR; Bonomo RA; Adams MD
    Antimicrob Agents Chemother; 2015 Jan; 59(1):536-43. PubMed ID: 25385117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. National survey of colistin resistance among carbapenemase-producing Enterobacteriaceae and outbreak caused by colistin-resistant OXA-48-producing Klebsiella pneumoniae, France, 2014.
    Jayol A; Poirel L; Dortet L; Nordmann P
    Euro Surveill; 2016 Sep; 21(37):. PubMed ID: 27685838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.